Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary

TRACON Pharmaceuticals

11/05/2022 22:56

* TRACON Pharmaceuticals Inc  TCON.OQ  reported a quarterly
adjusted loss of 48 cents​​ per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 42 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * TRACON Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 48 cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TRACON Pharmaceuticals Inc shares had fallen by 31.2% this
quarter and lost 34.7% so far this year.
    * The company reported a quarterly loss of $9.47 million.
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 11 at 09:56 p.m.  ​All
figures in US dollars unless otherwise stated